The EIF2AK4 gene helps cells sense when amino acids, the building blocks of protein, are low and adjust protein production during stress. If you carry pathogenic variants in both copies of this gene, it can cause a rare inherited form of pulmonary hypertension called pulmonary veno occlusive disease or pulmonary capillary hemangiomatosis. People may notice shortness of breath, tiredness, low oxygen levels, and strain on the heart as pressure builds in the small blood vessels of the lungs.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or regulating processes in the body. Some genes provide the directions for producing proteins, the parts of cells that do much of the work. Others mainly help determine when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
EIF2AK4Gene function
What if the gene works
The EIF2AK4 gene helps cells respond when amino acids, the building blocks of protein, are low. It slows protein production and shifts cell activity so cells can conserve resources and stay balanced during stress.
Risk
What if the gene does not work
Variants in the EIF2AK4 gene can range from milder to more severe. More severe variants can cause high blood pressure in the lungs, often with blocked lung veins, which may lead to breathlessness, low oxygen, and right heart strain.
Treatment
What does that mean for your treatment
Pathogenic variants in the EIF2AK4 gene can indicate a form of pulmonary vascular disease in which usual pulmonary arterial hypertension drugs may worsen fluid buildup in the lungs, so these medicines are used with extra caution and sometimes avoided. Supportive care and early lung transplant planning often become central to treatment.
Conditions associated with EIF2AK4
Gene function
What if the gene works
Your cells need ways to slow down and reset when fuel is low. The EIF2AK4 gene helps manage that response by sensing shortages of certain amino acids, the building blocks of protein. It also helps cells adjust protein production and conserve resources until conditions improve.
The EIF2AK4 gene helps cells detect when certain amino acids, the building blocks of protein, are running low. This gives cells an early signal that supplies are limited and that they need to adapt.
Its protein places a small chemical tag on eIF2α (a switch that starts protein production). This slows most protein making for a while, which is how the EIF2AK4 gene controls protein production during nutrient stress.
While overall protein production slows, cells can still make selected helper proteins that support recovery and balance. This focused response helps cells cope with low nutrients in a more controlled way.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and help shape normal human diversity, such as variation in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not lead to any noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the EIF2AK4 gene often reduce or stop production of a working cell stress protein, so cells lose part of an important response to strain. Many are loss-of-function variants: milder changes may leave some activity, while more severe variants can shut it off almost completely. This pattern helps explain how EIF2AK4 gene variants affect pulmonary veno-occlusive disease, with less remaining activity often linked to earlier or more marked disease.
How variants are linked to conditions
Pathogenic variants in both copies of the EIF2AK4 gene can cause pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis, rare inherited forms of pulmonary hypertension. Many people develop increasing shortness of breath, especially with walking or climbing stairs, and testing that finds biallelic EIF2AK4 variants can confirm the diagnosis. These EIF2AK4 gene variants linked to pulmonary veno-occlusive disease are the gene’s main well-established condition associations.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widespread in the general population. Most do not directly affect health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a certain diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For EIF2AK4, disease risk is usually driven mainly by having harmful changes in both copies of the gene, rather than by lifestyle. There is not enough evidence to say specific habits lower that inherited risk, but smoking and low-oxygen strain such as high altitude can make lung vessel problems harder on the body.
Inheritance of EIF2AK4 variants
EIF2AK4-related disease is inherited in an autosomal recessive pattern. In practical terms, how EIF2AK4 variants are inherited usually means a person needs to receive one altered copy of the EIF2AK4 gene from each parent to develop the condition. Parents who each carry one variant are typically unaffected carriers, and with each pregnancy there is a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child who inherits neither variant.
What does my EIF2AK4 result mean for my family?
For families with an EIF2AK4-related condition, close relatives may also carry the gene change even if they have no symptoms. Brothers and sisters may have the same condition or be carriers, and parents are usually carriers as well. Other relatives can sometimes carry the change too, so the result may be relevant beyond just one person in the family.
Genetic information
Genetic testing
How you find out about variants
To find variants in the EIF2AK4 gene, genetic testing uses a blood or saliva sample. In EIF2AK4 genetic testing for pulmonary hypertension, a lab reads the DNA code to look for changes linked to inherited disease. Results may identify a disease causing variant, find no relevant variant, or show a change whose meaning is still unclear.
When should I consider getting a genetic test?
Genetic testing for the EIF2AK4 gene can be worth considering if someone has unexplained high blood pressure in the lungs, especially when doctors suspect a rare inherited form that affects the tiny blood vessels in the lungs. It may also help when similar lung-vessel disease runs in the family.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it reveals depends on the condition and the type of variant involved. Over time, many factors shape how the body works, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other aspects of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can influence how your body responds to medicines. Small differences in genes can change how a drug is broken down, how strongly it acts, or how sensitive you are to side effects. This helps explain why the same treatment may work well for one person, work less well for another, or feel harder to tolerate even at standard doses.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. It focuses on links between genes and drugs to understand why the same treatment may work differently from one person to another. With many medicines, genes can influence both how strongly a drug works and how the body handles it. This information can help guide more informed, individualized treatment decisions. More on this topic is available in the LearnHub.
Drugs influenced by the EIF2AK4 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or adjusted. Questions about side effects, new symptoms, or how a treatment fits your overall health are best discussed with your doctor.
History
EIF2AK4 entered medical genetics fairly recently through research on rare forms of pulmonary high blood pressure. For many years, pulmonary veno occlusive disease and pulmonary capillary hemangiomatosis were described by their lung findings alone, without a clear genetic cause. In 2014, researchers identified harmful inherited variants in the EIF2AK4 gene in families and individuals with these conditions, which marked a major step in understanding why some cases run in families. Initially understood only through visible traits, later recognized as tied to a specific gene, these conditions came to be seen as closely related. This discovery helped bring genetic testing into the diagnostic picture and clarified that EIF2AK4 related disease often follows a recessive inheritance pattern, meaning both gene copies are affected.